Scientific Publications

A Prostate-Specific Antigen–Activated Channel-Forming Toxin as Therapy for Prostatic Disease
Article - JNCI, Vol.99, Issue 5 pp, 376-385

A Prostate-Specific Antigen (PSA) activated channel-forming toxin as therapy for prostatic disease
Poster - EORTC-NCI-AACR Symposium, November 2006, Prague, Czech Republic.

PSA-Activated Proaerolysin as a Prostate Specific Cancer Therapy
Abstract/Poster - AACR, April 2006, Washington DC, USA.

Tumouricidal effects of a PSA-activated pore-forming toxin
Abstract - AACR, April 2005, Anaheim, USA.

Kioi, M., et al., Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy.
Cancer Res, 2005. 65(18): p. 8388.

Kay, N.E., et al., A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells.
Leuk Res, 2005. 29(9): p. 1009.

Garland, L., et al., Phase I trial of intravenous IL-4 pseudomonas exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor.
J Immunother, 2005. 28(4): p. 376.

Weber, F., et al., Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.
J Neurooncol, 2003. 64(1-2): p. 125.

Kawakami, K., et al., Targeting interleukin-4 receptors for effective pancreatic cancer therapy.
Cancer Res, 2002. 62(13): p. 3575.

Husain, S.R., et al., Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model.
Nat Med, 1999. 5(7): p. 817.

What's New

May 15, 2008
Protox Doses First Patient In Phase 2 BPH Clinical Trial

May 13, 2008
Protox Reports 2008 First Quarter Results

May 5, 2008
Protox Announces Private Placement

April 30, 2008
Protox Announces Collaboration with FDA

 

Events

BioFinance
Toronto Marriott Eaton Centre Hotel (Trinity IV room) - Toronto, ON

When: May 7, 2008 10:30a.m. EDT

Presenter: Dr. Fahar Merchant, President & CEO

 

Stock Quote

LAST TRADE:$0.73
TRADE TIME:3:43PM EST
CHANGE:$-0.02 (-2.67%)
PREV CLOSE: $0.75
OPEN:$0.75
BID:$0.72
ASK:$0.73